Business HealthCanadian edibles company offers microdose option By Jennifer Blyth | February 27, 2022
HealthUVic study explores long-term effects of alcohol and cannabis during pregnancy By Jennifer Blyth | February 22, 2022
Health NewsNFL awards $1 million for 2 studies on cannabinoids effects By Associated Press | February 6, 2022
HealthFish on acid? Microdosing zebrafish with LSD shows its potential benefits for humans By The Canadian Press | February 5, 2022
Health NewsCan cannabis compound CBD block COVID? Maybe, but not what’s in stores, study finds By mcclatchy | January 25, 2022
HealthResearch shows psychedelic mushrooms can help treat depression. Is legalization on the horizon for Washington? By mcclatchy | January 23, 2022
Health NewsUniversity of Toronto researcher looks at cannabinoids to treat obesity By Jennifer Blyth | January 22, 2022
HealthNew research suggests CBD might help prime cells against COVID-19 By Canadian Evergreen Staff | January 16, 2022
HealthUBC Okanagan team studies cannabis use among Indigenous Peoples of Turtle Island By Canadian Evergreen Staff | January 8, 2022
Health NewsAn uneasy interaction: WSU researchers say cannabinoids can interfere with how medications metabolize in the body By mcclatchy | January 7, 2022
News HealthStudy explores medical cannabis use among Canadian veterans By Jennifer Blyth | January 3, 2022
HealthManitoba Metis Federation signs on for cannabis research project By Canadian Evergreen Staff | December 1, 2021
Health BusinessAs ketamine clinics emerge in Seattle to treat mental illness, so does safety and regulation debate By mcclatchy | November 29, 2021
Health BusinessPartnership to offer producers genetic analysis of psychedelic mushrooms, cannabis By Canadian Evergreen Staff | November 20, 2021
Business HealthVernon-based magic mushroom company sprouts mental health treatment By Brendan Shykora | November 20, 2021
